ipharmacenter Consulting services

From 1 January 2026, Australians will pay less for many prescription medicines listed on the Pharmaceutical Benefits Scheme (PBS), with the maximum co-payment for Medicare card holders reduced from $31.60 to $25 per prescription. The concessional co-payment remains capped at $7.70 per script until 1 January 2030, helping to ease cost-of-living pressures for people on lower incomes. About the PBS and Co-payments The PBS, funded by the Australian Government, subsidises the cost

Eisai and Biogen have announced that the United Arab Emirates (UAE) Ministry of Health and Prevention has granted approval for Leqembi...

LEQEMBI (Lecanemab) Gains Approval in South Korea for Alzheimer’s Disease Treatment EiSai and Biogen have announced that South Korea's...

Eisai submitted a marketing authorization application to South Korea's Ministry of Food and Drug Safety (MFDS) to seek approval for...